Authors: Li X, Chen Z, Zhang Y, Fan C, Chen L, Xu X, Chang J, Qiang W, Jiang H, Liu C.
DOI: 10.3389/fendo.2025.1722245
Abstract Summary
Hyperuricemia, a metabolic disorder linked to gout and cardiovascular disease, is rising in prevalence, especially among younger populations. This comprehensive review examines current treatments: Western drugs targeting uric acid excretion, synthesis, and breakdown, including novel URAT1 inhibitors; Traditional Chinese Medicine approaches using herbs and compounds that inhibit enzymes and regulate transporters; and emerging therapies like SGLT2 inhibitors and microbiota transplantation.
Why Brain? ðŸ§
Review examines hyperuricemia treatments including Western drugs, Traditional Chinese Medicine, and novel therapies like SGLT2 inhibitors and microbiota transplantation, guiding personalized care strategies.
License: CC BY.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
